WALLACE PHARMA LIMITED
Significant control: Simon Robert Geoffrey Tate (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Wallace Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Wallace Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
WALLACE PHARMA LIMITED is an active private limited company (company number 04063329) incorporated on 1 September 2000, registered in Brentwood. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2025, showing net assets of £291k, with 1 employee on average. Net assets were unchanged on the prior period.
By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
Ownership and control
- Mr Simon Robert Geoffrey Tate
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mrs Mary Joan Tate
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 1 September 200026 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 15 September 2027in 326 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £291k | — | £291k | — | — | — | 1 |
| 31 December 2024 | £291k | — | £291k | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £290,576 at 31 December 2025
- Incorporated five or more years agoIncorporated 1 September 2000
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 326 days
- Accounts period endNet assets £291k · small accounts
- Accounts period endNet assets £291k · small accounts
- Incorporated
Similar companies in Essex
- UK ANIMAL PRODUCTS LIMITEDMaldon · inc. Jun 1999
- KEW HEALTH AND BEAUTY LIMITEDBrentwood · inc. Jan 2004
- MALTRON INTERNATIONAL LIMITEDColchester · inc. Oct 1996
- MARLBOROUGH PHARMACEUTICALS LIMITEDBasildon · inc. Jan 2005
- GREEN HOUSE MONITORING LIMITEDChelmsford · inc. Feb 2010
- WESTECH SCIENTIFIC INSTRUMENTS LIMITEDChelmsford · inc. Jun 2012
All companies incorporated on 1 September 2000 · in Sept 2000.
Reminders for WALLACE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.